Steve Jensen Joins The Weinberg Group (now ProPharma Group)
February 3, 2015
The Weinberg Group (now ProPharma Group), the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has over 20 years of industry experience including executive roles at Iroko, Verus and SkyePharma. He has had responsibility for products under development and launch, including managing multiple FDA submissions and meetings. "Steve is a welcome addition to our team," said Matthew Weinberg, CEO. "His ability to synthesize a deep regulatory background in tandem with scientific expertise is the essence of what we do. His addition will strengthen the best team in the industry. We look forward to the leadership and guidance Steve will provide." Steve Jensen
Senior Vice President, Head of Regulatory Consulting
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...